CN1150035A - Glycolipid-gram pharmaceutical composition for treating diabetes mellitus - Google Patents
Glycolipid-gram pharmaceutical composition for treating diabetes mellitus Download PDFInfo
- Publication number
- CN1150035A CN1150035A CN 95118914 CN95118914A CN1150035A CN 1150035 A CN1150035 A CN 1150035A CN 95118914 CN95118914 CN 95118914 CN 95118914 A CN95118914 A CN 95118914A CN 1150035 A CN1150035 A CN 1150035A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- diabetes
- glycolipid
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 32
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 6
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 22
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 22
- 235000008434 ginseng Nutrition 0.000 claims abstract description 22
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 6
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 6
- 239000003814 drug Substances 0.000 claims description 25
- 241000208340 Araliaceae Species 0.000 claims description 21
- 239000009636 Huang Qi Substances 0.000 claims description 7
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 claims description 5
- 229930186217 Glycolipid Natural products 0.000 claims description 5
- 239000008517 radix Trichosanthis Substances 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- 239000000463 material Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 21
- 239000008280 blood Substances 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 9
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 241001633574 Adenophora stricta Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 241000218989 Trichosanthes Species 0.000 abstract 1
- 240000008042 Zea mays Species 0.000 abstract 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000005822 corn Nutrition 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 206010036067 polydipsia Diseases 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 206010020710 Hyperphagia Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 208000022530 polyphagia Diseases 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000008155 medical solution Substances 0.000 description 4
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 4
- 229960003105 metformin Drugs 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 208000007976 Ketosis Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 229960004580 glibenclamide Drugs 0.000 description 2
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 206010000410 Acetonaemia Diseases 0.000 description 1
- 208000013824 Acidemia Diseases 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010023379 Ketoacidosis Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- JLRGJRBPOGGCBT-UHFFFAOYSA-N Tolbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1 JLRGJRBPOGGCBT-UHFFFAOYSA-N 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 208000013527 cardiovascular neoplasm Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 1
- 201000008980 hyperinsulinism Diseases 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- ICFJFFQQTFMIBG-UHFFFAOYSA-N phenformin Chemical compound NC(=N)NC(=N)NCCC1=CC=CC=C1 ICFJFFQQTFMIBG-UHFFFAOYSA-N 0.000 description 1
- 229960003243 phenformin Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960005371 tolbutamide Drugs 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (2)
- The glycolipid gram pharmaceutical composition of 1, a kind of treatment " on disappear " diabetes is characterized in that it is made up of following materials of weight proportions:Cortex Lycii 10-20 part, Radix Ginseng 10-20 part, Radix Trichosanthis 10-20 part, Radix Rehmanniae 10-20 part, Radix Astragali 5-10 part, Rhizoma Dioscoreae 5-10 part, Fructus Schisandrae Chinensis 5-10 part, Radix Ophiopogonis 5-10 part, Rhizoma Polygonati 5-10 part, Radix Adenophorae (Radix Glehniae) 5-10 part, Semen Ziziphi Spinosae 5-10 part, Radix Puerariae 5-10 part, Arillus Longan 5-10 part, Stigma Maydis 5-10 part.
- The glycolipid gram pharmaceutical composition of 2, treatment according to claim 1 " on disappear " type diabetes is characterized in that it is made up of the medicine of following weight proportioning:Cortex Lycii 12-15 part, Radix Ginseng 12-15 part, Radix Trichosanthis 12-15 part, Radix Rehmanniae 12-15 part, Radix Astragali 5-7 part, Rhizoma Dioscoreae 5-7 part, Fructus Schisandrae Chinensis 5-7 part, Radix Ophiopogonis 5-7 part, Rhizoma Polygonati 5-7 part, Radix Adenophorae (Radix Glehniae) 5-7 part, Semen Ziziphi Spinosae 5-7 part, Radix Puerariae 5-7 part, Arillus Longan 5-7 part, Stigma Maydis 5-7 part.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95118914A CN1054524C (en) | 1995-11-10 | 1995-11-10 | Medicine composition for treating diabetes mellitus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN95118914A CN1054524C (en) | 1995-11-10 | 1995-11-10 | Medicine composition for treating diabetes mellitus |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1150035A true CN1150035A (en) | 1997-05-21 |
CN1054524C CN1054524C (en) | 2000-07-19 |
Family
ID=5081813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95118914A Expired - Fee Related CN1054524C (en) | 1995-11-10 | 1995-11-10 | Medicine composition for treating diabetes mellitus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1054524C (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100339119C (en) * | 2005-11-03 | 2007-09-26 | 蔡青 | Traditional Chinese medicine prepns. for treating diabete |
CN101062256B (en) * | 2007-05-26 | 2010-12-01 | 李丰军 | Chinese traditional combination medicine for treating diabetes |
CN102895537A (en) * | 2011-07-27 | 2013-01-30 | 陈冠卿 | Medicine treating diabetes |
-
1995
- 1995-11-10 CN CN95118914A patent/CN1054524C/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100339119C (en) * | 2005-11-03 | 2007-09-26 | 蔡青 | Traditional Chinese medicine prepns. for treating diabete |
CN101062256B (en) * | 2007-05-26 | 2010-12-01 | 李丰军 | Chinese traditional combination medicine for treating diabetes |
CN102895537A (en) * | 2011-07-27 | 2013-01-30 | 陈冠卿 | Medicine treating diabetes |
Also Published As
Publication number | Publication date |
---|---|
CN1054524C (en) | 2000-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103083531B (en) | Drug for treating diabetes | |
CN1475229A (en) | Antifatigue compound Chinese medicine prescription and its preparation method | |
CN1103305A (en) | Diabetes powder and its preparing method | |
CN1726953A (en) | Combination for treating diabetes and complicating diseases, and preparation | |
CN1159050C (en) | Compound traditional Chinese medicine preparation for treating type 2 diabetes | |
CN1137720C (en) | Chinese medicine for treating diabetes and its complication | |
CN1054524C (en) | Medicine composition for treating diabetes mellitus | |
CN1066332C (en) | Hypoglycemic compound capsule | |
CN1054525C (en) | Medicinal composition for treating diabetes involving lower jiao | |
CN1879783A (en) | A medicine for treating diabetes | |
CN1058403C (en) | A pharmaceutical composition for the treatment of diabetes | |
CN1062751C (en) | Compound Chinese and western medicinal compsn. for treating 'down elimination' diabetes | |
CN1063644C (en) | Compound Chinese and western medicinal compsn. for treating 'upper elimination' diabetes | |
CN113521134A (en) | Traditional Chinese medicine composition for treating type II diabetes and application thereof | |
CN100339119C (en) | Traditional Chinese medicine prepns. for treating diabete | |
CN1063645C (en) | Compound Chinese and western medicinal compsn. for treating 'medium elimination' diabetes | |
CN1314160A (en) | Oral pill for curing diabetes and its complication | |
CN1097333A (en) | A kind of pure plant health preparation glycolipid disappears and method for making | |
CN1076622C (en) | Chinese medicine for curing nephritis | |
CN1306830A (en) | Medicine for treating type II diabetes | |
CN1238013C (en) | Myocarditis treating Chinese medicine prepn | |
CN1183933C (en) | Medicine for treating incomplete kidney function and its prepn | |
CN1363386A (en) | Composition Chinese-medicinal herb pieces and preparing process thereof | |
CN1110176A (en) | Oral drug for curing diabetes and complicated angiocardiopathy | |
CN1111426C (en) | Diabetes treating medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Co-applicant after: Lin Yulin Co-applicant before: Zong Yuhua |
|
CB03 | Change of inventor or designer information |
Inventor after: Lin Yulin Inventor after: Chen Jinyan Inventor after: Lin Zuxian Inventor after: Fu Chunfu Inventor before: Chen Jinyan Inventor before: Lin Zuxian Inventor before: Fu Chunfu |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: CHEN JINYAN; LIN ZUXIAN; FU CHUNFU TO: LIN YULIN; CHEN JINYAN; LIN ZUXIAN;FU CHUNFU |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |